TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA

Clinical trials for TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA trials appear

Sign up with your email to follow new studies for TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for bone marrow failure: major trial tests drug combo to rebuild blood cells

Disease control Not yet recruiting

This study is testing whether adding an experimental drug called romiplostim N01 to standard immunosuppressive therapy works better than standard therapy alone for people newly diagnosed with severe aplastic anemia. It will involve 210 participants who have not yet received treat…

Matched conditions: TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA

Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA

Get alerted when new TREATMENT-NAÏVE SEVERE APLASTIC ANEMIA trials appear

New hope for bone marrow failure: major trial tests drug combo to rebuild blood cells